GI Oncology Weekly — Issue 7 — What the endpoint bought
August 26 – September 1, 2026
- FDA approval — Practice-shapingDaraxonrasib (RASONQUE)
- FDA approval — Practice-shapingZanidatamab + tislelizumab
- Worth watchingTALENTACE
- Worth watchingDEEPER
- On the radarJ-CAP-C
GI Oncology Weekly — Issue 6 — The order of operations
August 19 – August 25, 2026
- Practice-shapingTALENTOP
- Practice-shapingSTAR-TREC
- daraxonrasib — Practice-shapingESMO Express Update
- Worth watchingPaclitaxel oral solution
- On the radarSKYSCRAPER-07
GI Oncology Weekly — Issue 5 — What a test is for
August 12 – August 18, 2026
- Practice-shapingACS 2026 colorectal screening guideline
- Practice-shapingASCO Living Guideline v2026.1.2
- Worth watchingSimpleScreen CRC (PREEMPT CRC)
- On the radarDaraxonrasib resistance mapping
- On the radarγδ T-cell signature (AtezoBev in HCC)
GI Oncology Weekly — Issue 4 — What a result has to earn
August 5 – August 11, 2026
- Practice-shapingCheckMate 648 (5-year follow-up)
- Practice-shapingSOLARIS
- Worth watchingMountain-02
- Worth watchingDENEB
- On the radarLynch syndrome surveillance cohort (English NHS)